SelectScience
Join Free
Accelerating Science
NewsLife Sciences

Novozymes Grants Dyax Licences to its Albumin Fusion Technology, albufuse™ and Yeast-based Protein Expression Platform

Novozymes Delta Ltd
15 May 2008

Product news

Novozymes has announced that it has granted non-exclusive licenses for its proprietary albumin fusion technology, albufuse™, and yeast-based expression platform to Dyax Corp., a developer of novel biotherapeutics for unmet medical needs. Under the terms of the agreement, Dyax has been granted a non-exclusive research and development license for use of Novozymes’ technology to develop albumin fusions of Kunitz domain proteins and antibody fragments for therapeutic and diagnostic applications.

Novozymes’ albufuse™ is becoming increasingly recognised as a leading technology for effective half-life extension of protein-based drugs. A number of pre-clinical studies have demonstrated that albufuse™ fusions significantly enhance the circulatory half-life of a range of therapeutically active molecules. The technology is currently being clinically evaluated by several leading pharmaceutical and biotech companies for a range of human therapeutic applications.

Under the terms of the agreement, Dyax is also granted non-exclusive access to Novozymes' proprietary S. cerevisiae protein expression platform for the subsequent manufacture of lead albumin fusion molecules. Novozymes’ S. cerevisiae yeast expression platform has been commercially validated for a wide range of biotherapeutic applications and has been proven at commercial-scale through Novozymes’ lead product Recombumin®; the only commercially available recombinant human albumin authorised for use in the manufacture of human therapeutics.

“I am delighted to execute this licence agreement with Dyax,” commented Dr. David Mead, Business Development Director of Novozymes Biopharma. “This collaboration builds on our earlier successful research collaboration. Dyax is an exciting company to work with at all levels; we look forward to extending our relationship and the development of new biotherapies utilising our novel technologies.”

“We are very excited about extending our albufuse™ technology collaboration with Novozymes, and incorporating their S. cerevisiae expression platform,” commented Henry E. Blair, Chairman, President and Chief Executive Officer of Dyax.

Links

Novozymes Delta LtdCompany website

Tags

AntibodiesAntibodies are used in techniques such as confocal and fluorescence microscopy, flow cytometry, ELISA, ELISPOT, immunohistochemistry, western blotting and immunopreciptation. Select specific antigen reactivity, high specific affinity, low non-specific binding, monoclonal or polyclonal, primary or secondary antibodies and associated conjugates such as an enzyme or dye for visualization.Cell / Tissue CultureCell culture or tissue culture is used to study the biology of cells or tissues and to isolate cellular products in an environment which can be manipulated and well defined. Accurately control your culture environment with bioreactors or culture incubators, bind your cells to a surface or together with an extracellular matrix. Distinguish cell types with differential media or proliferate cells with certain characteristics using selective media. Enrich your media with supplements such as growth factors, sera and vitamins. Find the best cell and tissue culture products, kits and equipment in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.Genome AnalysisGenomics, the study of genomes, includes functional genomics, evolutionary genomics and comparative genomics. There are many genomic technologies such as DNA sequencing of whole genomes, computational biology and bioinformatics. DNA and nucleic acids must be isolated and concentrated from cells for analysis with kits, automated analyzers and software. Other useful technologies for studying genomics include PCR, microarrays and electrophoresis.ProteomicsProteomics is the systemic bioinformatics study of proteins and amino acids, including their structure, size, function and identification. Tools used in proteomics include chromatography, blotting and gels, protein arrays, mass spectrometry and ELISA and associated analysis software. Analyzers and proteomic systems should be sensitive, high resolution, fast and may be automated for high-throughput.ImmunologyImmunological techniques measure and characterize immune responses. Immunology kits and analysis systems often use techniques such as ELISA, radioimmunoassay (RIA) and immunodiffusion assays, Immunohistochemistry, and flow cytometry. Immunologists use equipment such as flow Cytometers, plate readers, plate washers and fluorescent microscopes.Gene Expression and Molecular CloningMolecular cloning is a set of techniques that utilizes vectors to transfer recombinant DNA into host cells and is an essential tool for investigating the expression of genes and proteins in bacterial or mammalian cells. A variety of vectors optimized for gene cloning and expression in a range of host organisms are available, alongside competent cells for genetic replication. Here, you can explore a range of molecular tools, high-quality genomic and cDNA libraries, premade clones, transformation and transfection reagents and mutagenesis or gene expression detection assays and expression arrays. Find the best gene expression and molecular cloning products in our peer-reviewed product directory: compare products, check customer reviews and receive pricing direct from manufacturers.

Related articles

Novozymes Grants Dyax Licences to its Albumin Fusion Technology, albufuse™ and Yeast-based Protein Expression Platform